Bufei Yishen Granule for Reducing Acute Exacerbation in GOLD Stage 3 or 4 COPD
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This study aims to establish the treatment scheme of Bufei Yishen granule for GOLD stage 3 or
4 chronic obstructive pulmonary disease (COPD), reducing acute exacerbation, improving
exercise capacity and forming high quality evidence.